Research advances in stereotactic radiotherapy for brain metastases
10.13491/j.issn.1004-714X.2025.03.026
- VernacularTitle:立体定向放疗在脑转移瘤中的研究进展
- Author:
Jiaxin DAI
1
,
2
;
Lin DUAN
2
,
3
;
Rencai FAN
2
;
Yan LING
4
;
Yulong LIU
2
Author Information
1. Department of Occupational Diseases, The Nuclear Industry 417 Hospital, Xi'an 710600, China
2. Clinical Cancer Diagnosis and Treatment Center, Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
3. Department ofOncology, People's Hospital of Manzhouli City, Manzhouli 021400, China
4. Department of Occupational Diseases, The Nuclear Industry 417 Hospital, Xi'an 710600, China.
- Publication Type:ReviewArticles
- Keywords:
Brain metastatic tumor;
Stereotactic radiotherapy;
Combined therapy;
Evaluation criteria of curative effect
- From:
Chinese Journal of Radiological Health
2025;34(3):463-470
- CountryChina
- Language:Chinese
-
Abstract:
Brain metastases are the most common intracranial tumors, and their incidence is increasing with the improvement of systemic treatments and survival rates. Optimal treatment usually requires a multidisciplinary approach, including radiotherapy, surgical resection, chemotherapy, targeted therapy, and immunotherapy. Stereotactic radiotherapy, compared to whole-brain radiotherapy, offers improved local control rates and reduced risk of neurocognitive impairment, and has become a new standard option for the treatment of brain metastases. Additionally, the widespread use of targeted and immune therapies in brain metastases has significantly improved the survival of some patients. This article reviews and integrates recent literature on the treatment of brain metastases and analyzes the role of stereotactic radiotherapy in comprehensive treatment, aiming to provide a reference for the selection of clinical treatment plans.
